Medical disclaimer. This page is for tracking and education only. It is not medical advice and it never recommends doses. Talk with your prescriber or care team before you change, lower, or stop any medication. Ozempic, Wegovy, Mounjaro, and Zepbound are named only to describe what readers search for.
How to use these guides
Start with the guide that matches where you are now. If you are looking for context on a specific medication, read coming off Ozempic. If you want the bigger picture, see what happens when you stop GLP-1.
For people focused on day to day tracking after treatment, how to prevent weight regain after GLP-1 covers habits and logs you can review with your clinician.
What every guide includes
Each guide is written for adults 18 plus and keeps the focus on education, not medical advice. Medication decisions belong to your prescriber or care team.
You will usually find plain language on weight trends, appetite, protein and fiber tracking, strength work, and a reminder to talk to a clinician if eating feels hard. The goal is to help you notice patterns, not to judge them.
One research example: in the SURMOUNT-4 trial, adults who completed 36 weeks of tirzepatide and then switched to placebo gained 14.0% of body weight from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%.
- Coming off Ozempic: what to plan and what to ask
- Stopping Wegovy: regain data and a maintenance plan
- Coming off Mounjaro: what trials show after stopping
- Coming off Zepbound: SURMOUNT-4 explained plainly
- What happens when you stop a GLP-1
- GLP-1 taper schedule: how to track one, not set one
- Weight regain after stopping Wegovy: STEP 1 extension
- How to prevent weight regain after GLP-1
- Food noise coming back after GLP-1: what to do
- Muscle loss on GLP-1: how much and how to limit it
- Strength training on GLP-1: a 2 to 3 day template
- Protein on GLP-1: why 1.2 to 1.6 g/kg is common advice
- Fibermaxxing: what it is and where to be careful
- Fiber on GLP-1: targets, constipation and pacing
- Meal ideas for low appetite that still hit protein
Join the iOS waitlist from Get the app.
Key facts
- In SURMOUNT-4 (JAMA 2024), from week 36 to week 88 people switched to placebo gained 14.0% of body weight, while those who continued tirzepatide lost a further 5.5%. Source
Sources
Last updated: